• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The administration of patient-reported outcome questionnaires in cancer trials: Interviews with trial coordinators regarding their roles, experiences, challenges and training.癌症试验中患者报告结局问卷的管理:就试验协调员的角色、经验、挑战及培训情况进行的访谈
Contemp Clin Trials Commun. 2017 Nov 23;9:23-32. doi: 10.1016/j.conctc.2017.11.009. eCollection 2018 Mar.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Qualitative analysis of clinical research coordinators' role in phase I cancer clinical trials.临床研究协调员在I期癌症临床试验中作用的定性分析
Contemp Clin Trials Commun. 2017 Sep 28;8:156-161. doi: 10.1016/j.conctc.2017.09.009. eCollection 2017 Dec.
4
Current practices in patient-reported outcome (PRO) data collection in clinical trials: a cross-sectional survey of UK trial staff and management.临床试验中患者报告结局(PRO)数据收集的当前实践:对英国试验工作人员和管理人员的横断面调查。
BMJ Open. 2016 Oct 3;6(10):e012281. doi: 10.1136/bmjopen-2016-012281.
5
Care coordinator delivered Method of Levels therapy for people reporting first-episode psychosis: Experiences and views of service user, care coordinator, and team manager participants of the CAMEO trial.护理协调员为首次发作精神病患者提供的分层治疗方法:CAMEO试验中服务使用者、护理协调员和团队经理参与者的经验与观点
BMC Psychiatry. 2024 Dec 4;24(1):878. doi: 10.1186/s12888-024-06286-x.
6
Care coordinator delivered method of levels therapy to improve engagement and other outcomes in early psychosis (CAMEO): protocol for a feasibility cluster-randomised controlled trial.护理协调员提供的分层治疗方法以改善早期精神病患者的参与度及其他结局(CAMEO):一项可行性整群随机对照试验方案
Pilot Feasibility Stud. 2024 Aug 31;10(1):117. doi: 10.1186/s40814-024-01529-w.
7
The oncology nurse coordinator: role perceptions of staff members and nurse coordinators.肿瘤护理协调员:工作人员和护理协调员的角色认知。
Isr J Health Policy Res. 2017 Nov 30;6(1):66. doi: 10.1186/s13584-017-0186-8.
8
Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists.临床试验中生活质量数据收集的不一致性:潜在的偏倚来源?对研究护士和试验者的访谈。
PLoS One. 2013 Oct 4;8(10):e76625. doi: 10.1371/journal.pone.0076625. eCollection 2013.
9
Management of Patient-Reported Outcome (PRO) Alerts in Clinical Trials: A Cross Sectional Survey.临床试验中患者报告结局(PRO)警报的管理:一项横断面调查。
PLoS One. 2016 Jan 19;11(1):e0144658. doi: 10.1371/journal.pone.0144658. eCollection 2016.
10
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

引用本文的文献

1
Uncovering the Professional Landscape of Clinical Research Nursing: A Scoping Review with Data Mining Approach.揭示临床研究护理的专业领域:采用数据挖掘方法的范围综述
Nurs Rep. 2025 Jul 24;15(8):266. doi: 10.3390/nursrep15080266.
2
Systematic review and meta-analysis: What's next - embracing complexity and improving patient care!系统评价与荟萃分析:下一步是什么——拥抱复杂性并改善患者护理!
Indian J Anaesth. 2025 Jan;69(1):6-9. doi: 10.4103/ija.ija_1356_24. Epub 2025 Jan 11.
3
15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis.导致泌尿生殖系统癌症药物获批的临床试验中15年患者报告结局:关于数据报告与分析质量的系统评价
EClinicalMedicine. 2024 Jan 5;68:102413. doi: 10.1016/j.eclinm.2023.102413. eCollection 2024 Feb.
4
Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice.卵巢癌患者报告结局:促进和加强临床试验及临床实践中症状、不良事件和治疗主观获益的报告
Patient Relat Outcome Meas. 2023 May 8;14:111-126. doi: 10.2147/PROM.S297301. eCollection 2023.
5
Ethical and practical considerations related to data sharing when collecting patient-reported outcomes in care-based child health research.在以患者为中心的儿童健康研究中收集患者报告结局数据时,与数据共享相关的伦理和实践考虑。
Qual Life Res. 2023 Aug;32(8):2319-2328. doi: 10.1007/s11136-023-03393-2. Epub 2023 Mar 31.
6
Patient-reported outcome measures as an outcome variable in sports medicine research.患者报告的结局指标作为运动医学研究中的一个结局变量。
Front Sports Act Living. 2022 Nov 2;4:1006905. doi: 10.3389/fspor.2022.1006905. eCollection 2022.
7
A review of patient-reported outcomes used for regulatory approval of oncology medicinal products in the European Union between 2017 and 2020.2017年至2020年期间欧盟用于肿瘤药品监管批准的患者报告结局综述。
Front Med (Lausanne). 2022 Aug 12;9:968272. doi: 10.3389/fmed.2022.968272. eCollection 2022.
8
Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer Forum.在肿瘤学剂量发现试验中使用患者报告结局:关键利益相关者和国家癌症研究所消费者论坛的调查。
Oncologist. 2022 Sep 2;27(9):768-777. doi: 10.1093/oncolo/oyac117.
9
Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops.改善临床试验方案中的患者报告结局部分:教育研讨会的混合方法评估。
Qual Life Res. 2022 Oct;31(10):2901-2916. doi: 10.1007/s11136-022-03127-w. Epub 2022 May 12.
10
Temporal Trends and Factors Associated With the Inclusion of Patient-Reported Outcomes in Heart Failure Randomized Controlled Trials: A Systematic Review.时间趋势和与心力衰竭随机对照试验中纳入患者报告结局相关的因素:系统评价。
J Am Heart Assoc. 2021 Nov 2;10(21):e022353. doi: 10.1161/JAHA.121.022353. Epub 2021 Oct 23.

本文引用的文献

1
EQ-5D and the EuroQol Group: Past, Present and Future.EQ-5D与欧洲生活质量小组:过去、现在与未来。
Appl Health Econ Health Policy. 2017 Apr;15(2):127-137. doi: 10.1007/s40258-017-0310-5.
2
Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review.减少患者报告结局(PRO)数据缺失的发生率及影响的设计、实施和报告策略:一项系统综述
BMJ Open. 2016 Jun 15;6(6):e010938. doi: 10.1136/bmjopen-2015-010938.
3
The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols.国际卵巢癌随机对照试验方案中的患者报告结局内容。
Qual Life Res. 2016 Oct;25(10):2457-2465. doi: 10.1007/s11136-016-1339-x. Epub 2016 Jun 13.
4
Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.对临床试验方案中患者报告结局(PRO)内容的系统评价。
PLoS One. 2014 Oct 15;9(10):e110229. doi: 10.1371/journal.pone.0110229. eCollection 2014.
5
Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists.临床试验中生活质量数据收集的不一致性:潜在的偏倚来源?对研究护士和试验者的访谈。
PLoS One. 2013 Oct 4;8(10):e76625. doi: 10.1371/journal.pone.0076625. eCollection 2013.
6
Patient-reported outcome alerts: ethical and logistical considerations in clinical trials.患者报告结局警报:临床试验中的伦理与后勤考量
JAMA. 2013 Sep 25;310(12):1229-30. doi: 10.1001/jama.2013.277222.
7
Practical and statistical issues in missing data for longitudinal patient-reported outcomes.纵向患者报告结局中缺失数据的实际问题与统计学问题
Stat Methods Med Res. 2014 Oct;23(5):440-59. doi: 10.1177/0962280213476378. Epub 2013 Feb 19.
8
The role of clinical trial nurses: an Australian perspective.临床试验护士的角色:澳大利亚视角
Collegian. 2012;19(4):239-46. doi: 10.1016/j.colegn.2012.02.005.
9
Clinician-trialist rounds: 5. Cointervention bias--how to diagnose it in their trial and prevent it in yours.
Clin Trials. 2011 Aug;8(4):440-2. doi: 10.1177/1740774511410995.
10
Identifying and avoiding bias in research.识别和避免研究中的偏见。
Plast Reconstr Surg. 2010 Aug;126(2):619-625. doi: 10.1097/PRS.0b013e3181de24bc.

癌症试验中患者报告结局问卷的管理:就试验协调员的角色、经验、挑战及培训情况进行的访谈

The administration of patient-reported outcome questionnaires in cancer trials: Interviews with trial coordinators regarding their roles, experiences, challenges and training.

作者信息

Mercieca-Bebber Rebecca, Calvert Melanie, Kyte Derek, Stockler Martin, King Madeleine T

机构信息

Central Clinical School, Sydney Medical School, University of Sydney, NSW 2006, Australia.

Psycho-oncology Co-operative Research Group, School of Psychology, University of Sydney, Level 6 North, Chris O'Brien Lifehouse C39Z, NSW 2006, Australia.

出版信息

Contemp Clin Trials Commun. 2017 Nov 23;9:23-32. doi: 10.1016/j.conctc.2017.11.009. eCollection 2018 Mar.

DOI:10.1016/j.conctc.2017.11.009
PMID:29696221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5898562/
Abstract

AIMS

To explore cancer trial coordinators' roles and challenges in administering patient-reported outcome (PRO) questionnaires, and establish what PRO-specific training and guidance they received and needed.

METHODS

Eligible cancer trial coordinators experienced with PRO assessment from approved Australian sites participated in an audio-recorded, semi-structured interview (transcribed verbatim). Recruitment continued until data saturation. Transcripts underwent content analysis.

RESULTS

Twenty coordinators participated (professional training: nursing (n = 12), science/research (n = 4), both (n = 4)). PRO administration formed a minor component of most (85%) coordinators' roles. PRO administration challenges included managing 'English second language' participants, participants' companions who attempted to complete questionnaires, burdensome questionnaires, and balancing their duty of care against trial requirements. Coordinators reported inconsistencies in PRO administration, which appeared to arise as a result of confusion and inconsistent or contradictory PRO training. Inconsistencies concerned whether/when they explained the purpose of PRO assessment, which participants they approached to complete PROs, and whether they used PRO trial data to inform care.Coordinators received PRO training from various sources; most commonly study-specific start-up meetings (45%) or from colleagues (30%). Two received no PRO-specific training. Despite the challenges reported, many (55%) felt they did not need further PRO training.

CONCLUSION

Trial coordinators receive inconsistent PRO-specific training and are often unclear how to prioritise different aspects of data quality when faced with everyday challenges, leading to inconsistent methods, missing data, poor quality data, and even bias. Agreement on how coordinators should prioritise the requirements of PRO studies is a necessary pre-requisite for the development of much-needed, consensus-based PRO administration guidelines.

摘要

目的

探讨癌症试验协调员在管理患者报告结局(PRO)问卷方面的作用和挑战,并确定他们接受了哪些以及需要哪些特定于PRO的培训和指导。

方法

来自澳大利亚获批站点、有PRO评估经验的合格癌症试验协调员参加了一次录音的半结构化访谈(逐字转录)。招募工作持续进行直至数据饱和。对访谈记录进行内容分析。

结果

20名协调员参与(专业培训情况:护理专业12名,科学/研究专业4名,两者兼具4名)。PRO管理是大多数(85%)协调员工作的一个次要组成部分。PRO管理面临的挑战包括应对“英语非母语”参与者、试图代填问卷的参与者同伴、问卷繁琐,以及在其护理职责与试验要求之间取得平衡。协调员报告称PRO管理存在不一致的情况,这似乎是由于困惑以及PRO培训不一致或相互矛盾所致。不一致之处涉及他们是否/何时解释PRO评估的目的、找哪些参与者来完成PRO问卷,以及他们是否使用PRO试验数据来指导护理。协调员从各种来源接受PRO培训;最常见的是特定研究的启动会议(45%)或同事(30%)。两名协调员未接受任何特定于PRO的培训。尽管报告了这些挑战,但许多人(55%)觉得他们不需要进一步的PRO培训。

结论

试验协调员接受的PRO特定培训不一致,并且在面对日常挑战时,往往不清楚如何对数据质量的不同方面进行优先级排序,从而导致方法不一致、数据缺失、数据质量差,甚至产生偏差。就协调员应如何对PRO研究的要求进行优先级排序达成共识,是制定急需的、基于共识的PRO管理指南的必要前提。